Business - Briefly   

Natco Pharma's new addition

HYDERABAD: Natco Pharma announced the latest addition to its basket of oncology drugs, Cantret. According to a release issued here on Monday, Cantret (Altretamine 50 mg) capsules are being made available in India for the first time and are used for treatment of recurrent/persistent ovarian cancer-a life threatening cancer that affects women generally in the age group of 50-55 years. The medicine is priced at Rs. 39,000 for 10 strips of 10 capsules each, against the imported medicine's price of Rs. 1 lakh per 100 capsules, it said.

Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Updates: Breaking News |

Stories in this Section

• 'Pass on the benefits of low cost deposits to customers'
• Industry views sought on WTO issues
• Birlas place Will before court
• L&T Infotech plans China centre
• Medicine Shoppe to double retail outlets
• CMC to change business composition
• Rally in auto stocks
• Rupee weakens
• National Insurance posts Rs. 71 crore profit
• Glenmark acquires two products
• Exchange rates
• Bullion rates
• State Bank hikes home loan rates
• ONGC Videsh acquires oil block
• Shrinking chips' size
• New director for Oriental Bank
• Vega Auto's plans
• Samkrg Pistons expansion plan
• Natco Pharma's new addition
• Acer launches mobile-enabled notebook
• Broiler prices down
• Hikal in pact with Bayer
• Syndicate Bank's bond issue
• Mediaware unveils new software
• Micro Technologies join hands with Girvan

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu